Clinical research involving cannabis has had a challenging history; until very recently (and arguably still) it remains an area of clinical research characterized by historically heavy regulation and seemingly endless […] Read More >>
The Canadian Health Food Association (CHFA) and the Canadian Hemp Trade Association (CHTA) released a white paper on the “Smart Regulation of CBD” calling for the federal government to remove […] Read More >>
dicentra Cannabis Consulting (dCC), Canada’s leading consulting firm for the cannabis industry, has been selected to provide education and expertise in the latest developments internationally in the cannabis industry. dCC […] Read More >>
Canada Cannabidiol (CBD) is a naturally-occurring phytocannabinoid in the Cannabis sativa L. plant and is responsible for many of the therapeutic properties associated with cannabis. It is important to know […] Read More >>
News of Canada’s cannabis legalization on October 17, 2018 made international headlines. Many people have taken the general impression from these headlines that it’s a wide open free for all market. This […] Read More >>
Update (June 28, 2018): Cannabis is added to Schedule II of the Natural Health Product Regulations. Contact us for further information. 1-866-647-3279 or info@dicentra.com. Update (June 28, 2018): CBD as […] Read More >>